Malignancy affects the hemostatic system and the hemostatic system affects malignancy. In
cancer patients there are a number of coagulation abnormalities which provide the …

Background Whether high preoperative D-dimer level has any impact on long-term survival
of patients with surgically treated non-small cell lung cancer (NSCLC) remains unclear …

Three structurally different fucoidans from the brown seaweeds Saccharina latissima (SL),
Fucus vesiculosus (FV), and Cladosiphon okamuranus (CO), two chemically modified …

Background Thrombin, the final enzyme of blood coagulation, is a multifunctional serine
protease also involved in the progression of cancer. Tumor cells may activate blood …

Purpose Here, this study verifies that cancer-associated thrombosis (CAT) accelerates
hypoxia, which is detrimental to the tumor immune microenvironment by limiting tumor …

Hypercoagulable state and disorganized angiogenesis are two conspicuous characteristics
during tumor progression. There are a considerable number of clinical trials focusing on the …

Colon adenocarcinoma (COAD) represents a significant health concern within the
population. Advancing our understanding of COAD is imperative for early detection …

Objectives To evaluate the possible synergic effect of cisplatin and low molecular weight
heparin (LMWH) on oral squamous cell carcinoma (OSCC). Materials and Methods Cisplatin …

Adhesion of acute promyelocytic leukemia (APL) cells to endothelial cells (EC) is among the
mechanisms of the APL-associated coagulopathy, responsible for early hemorrhagic deaths …

Introduction Intensive care unit (ICU) patients with renal insufficiency are more likely to
develop venous thromboembolism and are at an increased risk for bleeding. There is …